Haematologica (Jul 2024)
Response to DA-EPOCH-R is associated with activation of 'fitter' cytotoxic T-cells in patients with newly diagnosed double and triple hit high-grade B-cell lymphoma
- A. Vera de Jonge,
- Wassilis S.C. Bruins,
- Carolien Duetz,
- Charlotte L.B.M. Korst,
- Rosa Rentenaar,
- Meliha Cosovic,
- Merve Eken,
- Marie-Jose Kersten,
- Yorick Sandberg,
- Rozemarijn S. van Rijn,
- Rob Fijnheer,
- Pim Mutsaers,
- Vibeke K.J. Vergote,
- Djamila Issa,
- Aart Beeker,
- Yavuz M. Bilgin,
- Otto Visser,
- Erik van Werkhoven,
- Margaretha G.M. Roemer,
- Martine E.D. Chamuleau,
- Tuna Mutis
Affiliations
- A. Vera de Jonge
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- Wassilis S.C. Bruins
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- Carolien Duetz
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- Charlotte L.B.M. Korst
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- Rosa Rentenaar
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- Meliha Cosovic
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- Merve Eken
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- Marie-Jose Kersten
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- Yorick Sandberg
- Department of Internal Medicine, Maasstad Hospital, Rotterdam
- Rozemarijn S. van Rijn
- Department of Internal Medicine, Medisch Centrum Leeuwarden, Leeuwarden
- Rob Fijnheer
- Department of Internal Medicine, Meander Medisch Centrum, Amersfoort
- Pim Mutsaers
- Department of Hematology, Erasmus MC Cancer Institute, Rotterdam
- Vibeke K.J. Vergote
- Department of Hematology, University Hospitals Leuven, Leuven
- Djamila Issa
- Department of Internal Medicine, Jeroen Bosch Hospital, ’s-Hertogenbosch
- Aart Beeker
- Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp
- Yavuz M. Bilgin
- Department of Internal Medicine, Adrz, Goes
- Otto Visser
- Department of Internal medicine, Isala, Zwolle
- Erik van Werkhoven
- HOVON foundation, Rotterdam, The Netherlands; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam
- Margaretha G.M. Roemer
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- Martine E.D. Chamuleau
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- Tuna Mutis
- Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam
- DOI
- https://doi.org/10.3324/haematol.2024.285170
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
